Search research articles
Contact Us
Filters
Showing results (1-10 of 17) with videos related to
Page
of 2
Sort By:
Journal of the Chinese Medical Association : JCMA
|
February 3, 2026
Construction and application of a genetically engineered mouse model of gastric adenocarcinoma
Yelizhati Madeti, Xiaoyi Chong, Xiaotian Zhang
Experimental and Therapeutic Medicine
|
February 20, 2018
Overexpression of microRNA-506-3p aggravates the injury of vascular endothelial cells in patients with hypertension by downregulating Beclin1 expression
Fanfan Yi, Yugui Hao, Xiaoyi Chong, et al.
Human Cell
|
October 27, 2023
Tracking circulating PD-L1-positive cells to monitor the outcome of patients with gastric cancer receiving anti-HER2 plus anti-PD-1 therapy
Xiaoyi Chong, Yanyan Li, Jialin Lu, et al.
Aging
|
February 27, 2021
Integrative analysis of genomic, epigenomic and transcriptomic data identified molecular subtypes of esophageal carcinoma
Mingyang Ma, Yang Chen, Xiaoyi Chong, et al.
Cancers
|
September 9, 2022
Extracellular Vesicle-Derived Protein File from Peripheral Blood Predicts Immune-Related Adverse Events in Gastric Cancer Patients Receiving Immunotherapy
Fangli Jiang, Zhening Zhang, Xiaoyi Chong, et al.
Discover Oncology
|
February 1, 2026
Association of clinicopathological characteristics and baseline peripheral blood lymphocyte subsets with efficacy of first-line immunotherapy in advanced gastric cancer
Wenfei Li, Sai Ge, Liyang Mo, et al.
American Journal of Cancer Research
|
November 17, 2025
Comparison of Alpha-fetoprotein-positive and AFP-negative patients with advanced gastroesophageal junction or gastric cancer receiving immunotherapy: an analysis stratified by HER2 status
Huizhen Liu, Wenfei Li, Jialin Lu, et al.
Journal of Extracellular Vesicles
|
April 1, 2022
Plasma extracellular vesicle derived protein profile predicting and monitoring immunotherapeutic outcomes of gastric cancer
Cheng Zhang, Xiaoyi Chong, Fangli Jiang, et al.
Clinical and Translational Medicine
|
December 30, 2020
Clinical implications of plasma ctDNA features and dynamics in gastric cancer treated with HER2-targeted therapies
Cheng Zhang, Zuhua Chen, Xiaoyi Chong, et al.
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu
|
March 8, 2024
Clinicopathological significance and immunotherapeutic outcome of claudin 18.2 expression in advanced gastric cancer: A retrospective study
Changsong Qi, Xiaoyi Chong, Ting Zhou, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 17) with videos related to
Sort By:
Page
of 2
Journal of the Chinese Medical Association : JCMA
|
February 3, 2026
Construction and application of a genetically engineered mouse model of gastric adenocarcinoma
Yelizhati Madeti, Xiaoyi Chong, Xiaotian Zhang
Experimental and Therapeutic Medicine
|
February 20, 2018
Overexpression of microRNA-506-3p aggravates the injury of vascular endothelial cells in patients with hypertension by downregulating Beclin1 expression
Fanfan Yi, Yugui Hao, Xiaoyi Chong, et al.
Human Cell
|
October 27, 2023
Tracking circulating PD-L1-positive cells to monitor the outcome of patients with gastric cancer receiving anti-HER2 plus anti-PD-1 therapy
Xiaoyi Chong, Yanyan Li, Jialin Lu, et al.
Aging
|
February 27, 2021
Integrative analysis of genomic, epigenomic and transcriptomic data identified molecular subtypes of esophageal carcinoma
Mingyang Ma, Yang Chen, Xiaoyi Chong, et al.
Cancers
|
September 9, 2022
Extracellular Vesicle-Derived Protein File from Peripheral Blood Predicts Immune-Related Adverse Events in Gastric Cancer Patients Receiving Immunotherapy
Fangli Jiang, Zhening Zhang, Xiaoyi Chong, et al.
Discover Oncology
|
February 1, 2026
Association of clinicopathological characteristics and baseline peripheral blood lymphocyte subsets with efficacy of first-line immunotherapy in advanced gastric cancer
Wenfei Li, Sai Ge, Liyang Mo, et al.
American Journal of Cancer Research
|
November 17, 2025
Comparison of Alpha-fetoprotein-positive and AFP-negative patients with advanced gastroesophageal junction or gastric cancer receiving immunotherapy: an analysis stratified by HER2 status
Huizhen Liu, Wenfei Li, Jialin Lu, et al.
Journal of Extracellular Vesicles
|
April 1, 2022
Plasma extracellular vesicle derived protein profile predicting and monitoring immunotherapeutic outcomes of gastric cancer
Cheng Zhang, Xiaoyi Chong, Fangli Jiang, et al.
Clinical and Translational Medicine
|
December 30, 2020
Clinical implications of plasma ctDNA features and dynamics in gastric cancer treated with HER2-targeted therapies
Cheng Zhang, Zuhua Chen, Xiaoyi Chong, et al.
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu
|
March 8, 2024
Clinicopathological significance and immunotherapeutic outcome of claudin 18.2 expression in advanced gastric cancer: A retrospective study
Changsong Qi, Xiaoyi Chong, Ting Zhou, et al.
Page
of 2